Health Prob Civil.
1. WHO. Global tuberculosis report [Internet]. Geneva: WHO; 2022 [access 2024 May 20]. Available from: https://www.who.int/publications/i/item/9789240061729
2.
United Nations. Sustainable Development Goals [Internet]. New York: United Nations; 2022 [access 2025 April 20]. Available from: https://sdgs.un.org/
3.
WHO. Global tuberculosis report [Internet]. Geneva: WHO; 2023 [access 2024 May 20]. Available from: https://www.who.int/publications/i/item/9789240061729
4.
WHO. Sixty-Seventh World Health Assembly. Agenda item 12.1. Global strategy and targets for tuberculosis prevention, care and control after 2015 [Internet]. Geneva: WHO; 2015 [access 2024 March]. Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_R1-en.pdf
5.
WHO. Global tuberculosis report 2024 [Internet]. Geneva: WHO; 2024 [access 2024 March]. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2024
6.
Chi X, Song S, Cai H, Chen J, Qi Y. Associations of P2X7 polymorphisms with the odds of tuberculosis: a meta-analysis. International Archives of Allergy and Immunology. 2019; 179(1): 74-80. https://doi.org/10.1159/000494728
7.
Mehta N, Kaur M, Singh M, Chand S, Vyas B, Silakari P, et al. Purinergic receptor P2X₇: a novel target for anti-inflammatory therapy. Bioorganic & Medicinal Chemistry. 2014; 22(1): 54-88. https://doi.org/10.1016/j.bmc.2013.10.054
8.
Zhu X, Guo W, Ren G, He X, Hu Q, Zhang Y, et al. P2X7R gene polymorphisms are associated with increased risk of pulmonary tuberculosis in the Tibetan Chinese population. The American Journal of Tropical Medicine and Hygiene. 2016; 95(5): 1016-1020. https://doi.org/10.4269/ajtmh.16-0056
9.
Ge HB, Chen S. A meta-analysis of P2X7 gene-1513A/C polymorphism and pulmonary tuberculosis susceptibility. Human Immunology. 2016; 77(1): 126-130. https://doi.org/10.1016/j.humimm.2015.11.009
10.
Sgaragli G, Frosini M. Human tuberculosis I. Epidemiology, diagnosis and pathogenetic mechanisms. Current Medicinal Chemistry. 2016; 23(25): 2836-2873. https://doi.org/10.2174/0929867323666160607222854
11.
Amiri A, Sabooteh T, Ahmadi SAY, Azargoon A, Shahsavar F. Association of P2X7 gene common polymorphisms with pulmonary tuberculosis in Lur population of Iran, Egyptian Journal of Medical Human Genetics. 2018; 19(3): 231-234. https://doi.org/10.1016/j.ejmhg.2017.12.002
12.
Wu J, Lu L, Zhang L, Ding Y, Wu F, Zuo W, et al. Single nucleotide polymorphisms in P2X7 gene are associated with serum immunoglobulin G responses to Mycobacterium tuberculosis in tuberculosis patients. Disease Markers. 2015; 671272. https://doi.org/10.1155/2015/671272
13.
Shamsi M, Zolfaghari MR, Farnia P. Association of IFN-γ and P2X7 receptor gene polymorphisms in susceptibility to tuberculosis among Iranian patients. Acta Microbiologica et Immunologica Hungarica. 2016; 63(1): 93-101. https://doi.org/10.1556/030.63.2016.1.7
14.
Chaudhary A, Singh JP, Sehajpal PK, Sarin BC. P2X7 receptor polymorphisms and susceptibility to tuberculosis in a North Indian Punjabi population. The International Journal of Tuberculosis and Lung Disease. 2018; 22(8): 884-889. https://doi.org/10.5588/ijtld.18.0023
15.
Fernando SL, Saunders BM, Sluyter R, Skarratt KK, Goldberg H, Marks GB, et al. A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis. American Journal of Respiratory and Critical Care Medicine. 2007; 175(4): 360-366. https://doi.org/10.1164/rccm.200607-970OC
16.
Xiao J, Sun L, Yan H, Jiao W, Miao Q, Feng W, et al. Meta-analysis of P2X7 gene polymorphisms and tuberculosis susceptibility. FEMS Immunology & Medical Microbiology. 2010; 60(2): 165-170. https://doi.org/10.1111/j.1574-695X.2010.00735.x
17.
De Marchi E, Orioli E, Dal Ben D, Adinolfi E. Chapter two – P2X7 receptor as a therapeutic target. Advances in Protein Chemistry and Structural Biology. 2016; 104: 39-79. https://doi.org/10.1016/bs.apcsb.2015.11.004
18.
CDC. Clinical overview of tuberculosis disease [Internet]. Atlanta: CDC; 2024 [access 2024 March]. Available from: https://www.cdc.gov/tb/hcp/clinical-overview/tuberculosis-disease.html
19.
CDC. Tuberculosis disease overview [Internet]. Atlanta: CDC; 2025 [access 2025 May]. Available from: https://www.cdc.gov/global-hiv-tb/media/pdfs/2025/03/2025_DGHT-TB-Overview-Factsheet.pdf
20.
Pinheiro Mascarenhas MA, Baroni Aurilio R, Godinho da Fonseca GG, Bueno Fischer G, Sant’Anna CC, Camargos P. Genetics of childhood tuberculosis: a scoping review. Paediatric Respiratory Reviews. Forthcoming 2025. https://doi.org/10.1016/j.prrv.2025.02.002
21.
Yi L, Cheng D, Shi H, Huo X, Zhang K, Zhen G. A meta-analysis of P2X7 gene-762T/C polymorphism and pulmonary tuberculosis susceptibility. PLoS ONE. 2014; 9(5): e96359. https://doi.org/10.1371/journal.pone.0096359
22.
Wu G, Zhao M, Gu X, Yao Y, Liu H, Song Y. The effect of P2X7 receptor 1513 polymorphism on susceptibility to tuberculosis: a meta-analysis. Infection, Genetics and Evolution. 2014; 24: 82-91. https://doi.org/10.1016/j.meegid.2014.03.006
23.
Zheng X, Li T, Chen Y, Pan H, Zhang Z, Dai Y, et al. Genetic polymorphisms of the P2X7 gene associated with susceptibility to and prognosis of pulmonary tuberculosis. Infection, Genetics and Evolution. 2017; 53: 24-29. https://doi.org/10.1016/j.meegid.2017.05.003
24.
Varahram M, Farnia P, Velayati AA. Susceptibility to tuberculosis among pulmonary tuberculosis patients: P2X7 and TNF-α gene polymorphisms. International Journal of Mycobacteriology. 2015; 4(Suppl. 1): 133. https://doi.org/10.1016/j.ijmyco.2014.11.011
25.
Taheri M, Sarani H, Moazeni-Roodi A, Naderi M, Hashemi M. Association between P2X7 polymorphisms and susceptibility to tuberculosis: an updated meta-analysis of case-control studies. Medicina (Kaunas, Lithuania). 2019; 55(6): 298. https://doi.org/10.3390/medicina55060298
26.
Keikha M, Karbalaei M. P2X7polymorphism(rs3751143) and its reliability as a diagnostic biomarker for tuberculosis: a systematic review and meta-analysis. Indian Journal of Tuberculosis. 2022; 69(1): 85-89. https://doi.org/10.1016/j.ijtb.2021.04.004
27.
Konuk E, Sallakcı N, Yeğın O. Interferon gamma IFN-γ promoter and P2X7 polymorphisms in Turkish tuberculosis patients. Akdeniz Tıp Dergisi. 2016; 2(3): 133-142. https://doi.org/10.17954/amj.2016.57
28.
Alshammari EMA, Mandal RK, Wahid M, Dar SA, Jawed A, Areeshi MY, et al. Genetic association study of P2x7 A1513C (rs 3751143) polymorphism and susceptibility to pulmonary tuberculosis: a meta-analysis based on the findings of 11 case-control studies. Asian Pacific Journal of Tropical Medicine. 2016; 9(12): 1150-1157. https://doi.org/10.1016/j.apjtm.2016.11.006
29.
De R, Kundu JK. Tuberculosis risk in P2X7 1513A/C polymorphism of the tribes of Jhargram, West Bengal. International Journal of Zoology Studies. 2017; 2(6): 189-193.
30.
Shafiek H, Shabana A, El-Seedy A, Khalil Y. P2X7 1513A/C loss-of-function polymorphism and active tuberculosis disease in a cohort of Egyptian population: a pilot study. Egypt J Med Hum Genet. 2022; 23: 89. https://doi.org/10.1186/s43042-022-00304-x
31.
Mukhtar H, Eldaif W, Arbab M, Gassom A, Musa H. Association of P2X7 1513A/C polymorphism with susceptibility to tuberculosis. International Journal of Infectious Diseases. 2020; 101(Suppl. 1): 182-183. https://doi.org/10.1016/j.ijid.2020.09.488
32.
Mukhtar HSEH, Eldaif WAH, Gassoum A, Arbab MA, Musa HH. Association of P2X7 1513A/C polymorphism with susceptibility to tuberculosis among Sudanese patients. Microbiol Infect Dis. 2018; 2(3): 1-6. https://doi.org/10.33425/2639-9458.1040
33.
Souza de Lima D, Ogusku MM, Sadahiro A, Pontillo A. Inflammasome genetics contributes to the development and control of active pulmonary tuberculosis. Infection, Genetics and Evolution. 2016; 41: 240-244. https://doi.org/10.1016/j.meegid.2016.04.015
34.
Semple C, Choi KYG, Kroeker A, Denechezhe L, Orr P, Mookherjee N, et al. Polymorphisms in the P2X7 receptor, and differential expression of toll-like receptor-mediated cytokines and defensins, in a Canadian indigenous group. Scientific Reports. 2019; 9(1): 14204. https://doi.org/10.1038/s41598-019-50596-0
Copyright: © 2025 Pope John Paul II State School of Higher Education in Biała Podlaska. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
